
GlaxoSmithKline’s chief executive Sir Andrew Witty received bonuses “lower than they otherwise might have been” last year due to the …

Sanofi has announced a mixed bag for its full year results as analysts have questioned why its forecasts for the …
Multiple sclerosis drug Gilenya, with sales rising 62% year-on-year to $1.9 billion, was one of the stars of last year …

The effectiveness of healthcare communications is often more reliant on who’s delivering the message than the content of the message …

GlaxoSmithKline is to remove individual staff sales targets and end doctor payments for activities that promote its products. The UK …

A catastrophic decline in sales of asthma medicine Singulair is among the key reasons why Merck’s pharma revenue fell 12% …

Johnson & Johnson saw overall sales rise 8.5% year-on-year in the second quarter of 2013, with the US healthcare group …
Novartis’ sales of pharma products were unchanged in the first quarter of 2013 at $7.9 billion, with pricing flat, the …
E-detailing has come at a time of great change in the pharmaceutical industry. The economic recession hit hard with pressure …
This is the introductory article to the ‘Success Factors in Value Communication Design’ series; a set of articles that examine and explain …
The global pharma market is forecast to reach $880 billion by 2011, driven by growth in the Chinese market. Analysts …
Doctors.net.uk, the UK’s largest and most active online network of healthcare professionals, has strengthened its pharmaceutical team with two appointments. …
New research suggests that the pharma world is going to be shaken up over the next few years – although …

Ask almost any pharmaceutical marketer where the future growth lies for the industry, and the answer will be almost certainly …
Research funded by the Chartered Institue of Management Accountants (CIMA) has helped Cranfield School of Management unveil a new framework …